In terms of sales, Guangzhou Pharmaceutical Co., Ltd. is the largest manufacturer of proprietary Chinese medicines in China. It has a long history in Chinese patent medicine manufacturing industry, with many time-honored brands and rich product resources. At present, more than 400 varieties of 23 dosage forms are produced, including 40 national second-class protected varieties of traditional Chinese medicine, of which 20 products are exclusively produced by Guangyao. All nine production enterprises under our company have passed the national GMP certification, and fully implemented the SAPR3/ERP system management with international advanced level.
Guangyao is also one of the largest pharmaceutical traders in China, with the largest pharmaceutical retail network and pharmaceutical logistics distribution center in South China. Now we are engaged in 10000 kinds of western medicine, Chinese medicine and medical device products, among which 100 kinds of well-known foreign brand medical products are exclusive agents.
Nowadays, GPHL has attracted the attention and praise of domestic and foreign capital markets and industries by virtue of its good business performance, standardized market operation and efficient management level.
Guangzhou Pharmaceutical Co., Ltd. is a joint-stock company approved by the National Economic System Reform Commission. [1997] 139 was exclusively initiated by Guangzhou Pharmaceutical Group Co., Ltd., and was established with its state-owned assets related to its production and operation assets after reorganizing its eight Chinese medicine production enterprises and three pharmaceutical trading enterprises. Approved by the National Economic System Reform Commission [1997] 145 and the the State Council Securities Commission [1997]56, the company was listed and issued 2 1997 1997 in 10. 200 1 1 1 Approved by China Securities Regulatory Commission, the company issued 78 million ordinary shares (A shares).